Prof. Dr. Ali Serdar Fak
Cardiac SurgeryVerified
- 29+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Heart Surgery
Heart transplantation
What heart transplantation is, when it is considered, how the donor-heart operation is carried out, why access for foreign patients is limited by national organ allocation rules, approximate costs in Turkey against the UK, US and Germany, how it compares with a ventricular assist device, what survival data show, recovery, rejection and infection risks, and how to check a transplant centre.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Heart Surgery
- Hospitals
- 2
- Verified
- 2
- Price from
- Price on request
Verified surgeons for Heart Transplantation
2 doctors Compare doctors, ratings and prices — ask any of them for a free quote.
Dr. Bülent İlçöl
Cardiac SurgeryVerified
- 25+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Heart transplantation in Turkey: what it is and when it is needed
Heart transplantation is an operation in which a diseased heart is removed and replaced with a healthy heart from a deceased donor. It is a last-line treatment for people whose heart has failed so badly that medicines, devices and other surgery no longer keep them well. The new heart takes over the circulation, and the recipient then takes immune-suppressing medicine for life so that the body does not reject the organ. It is a major operation with a long preparation and an even longer follow-up, and in Turkey it is carried out in large university and city hospitals with dedicated transplant teams.
This guide explains how the operation works, who is considered, the legal limits on access for international patients, approximate costs in Turkey compared with the UK, US and Germany, what survival figures show, and how recovery proceeds. For other heart procedures see our cardiology and heart surgery treatments in Turkey.
Who needs a heart transplant, and who is not suitable?
The usual reasons are advanced heart failure from dilated or other cardiomyopathy, severe coronary artery disease with a very weak pump, and some congenital or valve-related conditions in which the muscle has failed beyond repair. A transplant is considered when ejection fraction is very low, symptoms persist at rest or on minimal effort despite full medical treatment, and there are repeated hospital admissions.
Transplant teams look at the whole person. Factors that can rule a transplant out or delay it include active cancer, serious infection, severe irreversible lung, liver or kidney disease, uncontrolled diabetes with organ damage, current smoking, substance misuse and inability to follow a strict medication plan. Age limits vary by centre. Because a donor heart is scarce, the team must judge that you are likely to benefit for many years.
Can foreign patients have a heart transplantation in Turkey?
This is the question to settle first. Deceased-donor organs in Turkey are allocated through a national waiting list run under Turkish transplant law, and in most cases the list is open to Turkish citizens and residents rather than to people who travel only for treatment. A family-donor route does not exist for hearts, because a heart cannot be taken from a living person. For that reason many visitors cannot be placed on the list, and any clinic promising a donor heart on a fixed date to a non-resident should be treated with caution.
What a foreign patient can often do in Turkey is a full assessment, advanced heart-failure treatment, device therapy and, for residents or those who qualify under the rules, a listing evaluation. Ask the hospital in writing whether you are eligible, under which regulation and who authorises it, before you plan travel or pay a deposit. Illegal organ trade exists worldwide; do not take part in it, however it is presented.
How does a heart transplant operation work?
When a suitable donor heart becomes available, matched for blood group and body size, the recipient is called in and prepared at short notice. Under general anaesthesia the surgeon opens the breastbone, connects the patient to a heart-lung machine and removes the failing heart, leaving the back walls of the upper chambers in place. The donor heart is then sewn in at the atria, the aorta and the pulmonary artery. Once blood flows through it, the heart usually restarts, sometimes with a small electrical shock, and the patient is gradually taken off the machine.
The operation takes about four to six hours. Afterwards the patient is looked after in intensive care, usually for several days, with the first doses of immune-suppressing medicine given in the hospital. Biopsies of the heart muscle are taken at planned intervals to check for rejection.
Heart transplantation cost in Turkey compared with the UK, US and Germany
The figures below are wide, approximate ranges for the whole episode, not hospital quotes. A transplant for a non-resident is uncommon, so a written, itemised estimate matters more than any average.
| Country | Approximate cost range |
|---|---|
| Turkey | €60,000 – €150,000 |
| United Kingdom | €150,000 – €300,000 |
| United States | €400,000 – €1,000,000 |
| Germany | €150,000 – €300,000 |
What changes the price: pre-transplant assessment and tests, the length of intensive-care and ward stay, any bridging device used before the operation, treatment of complications, rejection biopsies and the first months of immune-suppressing medicine. A quote should say what is included and what happens if the stay is longer than planned.
Heart transplant, ventricular assist device or other surgery?
A transplant is not the only advanced option, and a heart-failure team will review the alternatives with you. A left ventricular assist device (LVAD) is a pump placed beside the failing heart; it is used as a bridge to transplant or as a long-term treatment. Surgery on the coronary arteries or valves can help when the muscle is still repairable, as with coronary bypass surgery or aortic valve replacement.
| Option | Suits | Typical limits |
|---|---|---|
| Heart transplant | End-stage failure with no repairable cause | Donor shortage; lifelong immune suppression |
| LVAD | Severe left-sided failure, as a bridge or long-term | Driveline infection, clots, bleeding; battery dependence |
| Bypass or valve surgery | Failure caused by blocked arteries or a faulty valve | Only helps if the muscle can still recover |
| Medication and devices | Early to moderate failure | Do not restore a failed muscle |
If both the heart and the lungs are damaged, a combined operation may be discussed; see heart and lungs transplantation.
Heart transplantation survival: what does the evidence say?
International registries, such as the one kept by the International Society for Heart and Lung Transplantation, show that most adult recipients are alive five years after the operation and that median survival is more than ten years, with results better for people who survive the first year. These are averages across many centres; your own outlook depends on age, the cause of heart failure, other illnesses and how closely you follow the medication plan. Early deaths are mostly from graft failure, infection and rejection, and later ones from chronic rejection of the heart's arteries, infections and cancers linked to immune suppression. A centre should be willing to share its own volume and outcomes, not just registry averages.
Recovery after a heart transplant: what to expect step by step
Most patients spend one to two weeks in hospital, with the first days in intensive care. After discharge you remain close to the transplant centre for the first weeks to allow frequent blood tests, echocardiograms (see echocardiography) and biopsies. Cardiac rehabilitation begins early with walking and builds over months. Breastbone healing takes about six to eight weeks, during which lifting is restricted, and driving usually resumes after a few weeks if the surgeon agrees. Many recipients return to light work after three to six months. Flying is possible once the team agrees, but long-distance travel in the first months is often avoided because of infection risk and the need for monitoring.
Rejection, infection and other risks of heart transplantation
Every transplant carries risks. The main ones are acute rejection, which is treated by adjusting medicines; infection, because the immune system is deliberately damped; kidney damage from some anti-rejection drugs; high blood pressure and cholesterol; diabetes; bone thinning; certain skin cancers and lymphomas; and cardiac allograft vasculopathy, a gradual narrowing of the new heart's arteries. Bleeding, stroke, arrhythmia and anaesthetic problems can occur around the operation. The British Heart Foundation, NHS Blood and Transplant and the ISHLT describe these risks and the need for lifelong follow-up. Ask who will manage your medicines and monitoring once you are back home.
How to choose a transplant centre, red flags and questions to ask
Choose a centre that runs an established heart-failure and transplant programme with its own cardiac surgeons, cardiologists, intensive-care and transplant coordinators, and that is open about its volume and results. Red flags include a promised donor heart or date, a price quoted without an assessment, no written confirmation of legal eligibility, no named transplant team and no plan for long-term follow-up. Read how our process works and request a plan through the free quote page, so the hospital can review your records first.
- Am I eligible for listing as a non-resident, and under which rule?
- How many heart transplants does the centre perform each year, and what are its one-year results?
- Which assessment tests do I need, and can some be done at home?
- What does the estimate include, and what happens if the stay is longer?
- Who monitors my medicines and biopsies after I leave Turkey?
Hospitals with Cardiac Surgery in Turkey
Frequently asked questions
A heart transplant replaces a failing heart with a healthy donor heart from a deceased donor. It is considered when heart failure no longer responds to medicines, devices or other surgery, and it requires lifelong immune-suppressing medication to prevent rejection.
Access is limited. Donor hearts are allocated through a national waiting list, which in most cases is open to citizens and residents. Ask a hospital in writing whether you are eligible and under which rule, and be cautious of anyone promising a donor heart on a set date.
A wide approximate range is €60,000 to €150,000 for the whole episode, against about €150,000 to €300,000 in the UK. The price depends on the assessment, intensive-care stay, any bridging device and complications, so ask for an itemised written estimate.
Hospital stay is typically one to two weeks. Breastbone healing takes six to eight weeks, and many people return to light work after three to six months. Frequent clinic visits, blood tests and biopsies continue for the first year.
Registry data show most adult recipients are alive at five years, with median survival beyond ten years. Individual outcomes vary with age, the cause of heart failure, other health problems and how consistently medication is taken.
Active cancer, serious infection, severe irreversible disease of other organs, current smoking or substance misuse, and inability to follow the medication plan can rule a transplant out. Each centre applies its own age and health criteria after a full assessment.
A transplant replaces the heart; an LVAD is a mechanical pump that helps a failing heart pump blood. LVADs are used while waiting for a transplant or as long-term treatment when a transplant is not possible.
Yes. Rejection is most likely in the first year and is checked with blood tests, echocardiograms and heart muscle biopsies. Most episodes are treated by adjusting immune-suppressing medication, but severe or repeated rejection can damage the new heart.
Plan for several weeks. After one to two weeks in hospital you usually stay near the centre for frequent checks before the team agrees you can travel home, which may take longer if there are complications.
Patient stories